R Squared Ltd increased its position in shares of Plexus Corp. (NASDAQ:PLXS – Free Report) by 84.0% during the 2nd quarter, Holdings Channel reports. The firm owned 2,980 shares of the technology company’s stock after purchasing an additional 1,360 shares during the quarter. R Squared Ltd’s holdings in Plexus were worth $403,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. TD Private Client Wealth LLC boosted its stake in Plexus by 185.6% in the first quarter. TD Private Client Wealth LLC now owns 514 shares of the technology company’s stock valued at $66,000 after acquiring an additional 334 shares during the last quarter. CWM LLC boosted its stake in Plexus by 65.7% in the second quarter. CWM LLC now owns 537 shares of the technology company’s stock valued at $73,000 after acquiring an additional 213 shares during the last quarter. Banque Transatlantique SA purchased a new position in Plexus in the first quarter valued at about $71,000. N.E.W. Advisory Services LLC purchased a new position in Plexus in the first quarter valued at about $87,000. Finally, Meeder Asset Management Inc. purchased a new position in Plexus in the first quarter valued at about $121,000. 94.45% of the stock is currently owned by hedge funds and other institutional investors.
Plexus Stock Performance
Shares of PLXS stock opened at $143.92 on Friday. The stock has a market capitalization of $3.88 billion, a P/E ratio of 22.99 and a beta of 0.80. The company has a current ratio of 1.58, a quick ratio of 0.74 and a debt-to-equity ratio of 0.06. The firm’s 50 day moving average is $141.04 and its 200 day moving average is $133.85. Plexus Corp. has a 12 month low of $103.43 and a 12 month high of $172.89.
Analyst Ratings Changes
PLXS has been the topic of a number of research analyst reports. Weiss Ratings reiterated a “hold (c+)” rating on shares of Plexus in a research note on Wednesday, October 8th. Stifel Nicolaus set a $150.00 target price on shares of Plexus in a research note on Friday. Sidoti cut shares of Plexus from a “buy” rating to a “neutral” rating and set a $150.00 target price on the stock. in a research note on Friday. Wall Street Zen cut shares of Plexus from a “strong-buy” rating to a “buy” rating in a research note on Sunday, October 19th. Finally, Williams Trading set a $165.00 price target on shares of Plexus in a research note on Monday, September 22nd. Two research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $159.00.
Read Our Latest Stock Report on PLXS
Insider Buying and Selling at Plexus
In related news, CFO Patrick John Jermain sold 2,500 shares of the company’s stock in a transaction that occurred on Wednesday, August 27th. The shares were sold at an average price of $137.71, for a total transaction of $344,275.00. Following the sale, the chief financial officer owned 20,959 shares of the company’s stock, valued at approximately $2,886,263.89. This represents a 10.66% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, COO Oliver K. Mihm sold 2,102 shares of the company’s stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $130.43, for a total transaction of $274,163.86. Following the sale, the chief operating officer directly owned 21,155 shares in the company, valued at $2,759,246.65. This trade represents a 9.04% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 15,856 shares of company stock worth $2,142,440 in the last ninety days. Insiders own 1.76% of the company’s stock.
About Plexus
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Further Reading
- Five stocks we like better than Plexus
- How to Calculate Stock Profit
- Rayonier-PotlatchDeltic Merger Signals Industry Upside
- What is the S&P/TSX Index?
- Hims & Hers Short Interest Nears All-Time High, Buy The Dip?
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- This Defense Stock Has a $57B Backlog and New AI Tailwinds
Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXS – Free Report).
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
